Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-21-044051
Filing Date
2021-08-20
Accepted
2021-08-20 16:05:08
Documents
2
Period of Report
2021-08-19

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea146189-6k_regencell.htm 6-K 11939
2 PRESS RELEASE ON EXERCISE OF THE UNDERWRITER'S OVER-ALLOTMENT OPTION ea146189ex99-1_regencell.htm EX-99.1 10481
  Complete submission text file 0001213900-21-044051.txt   23509
Mailing Address 11/F FIRST COMMERCIAL BUILDING 33-35 LEIGHTON ROAD, CAUSEWAY BAY HONG KONG K3 999077
Business Address 11/F FIRST COMMERCIAL BUILDING 33-35 LEIGHTON ROAD, CAUSEWAY BAY HONG KONG K3 999077 852 2155 0823
Regencell Bioscience Holdings Ltd (Filer) CIK: 0001829667 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9
Type: 6-K | Act: 34 | File No.: 001-40617 | Film No.: 211193853
SIC: 2833 Medicinal Chemicals & Botanical Products